Techpool Bio-Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Techpool Bio-Pharma Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10892
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Techpool Bio-Pharma Co Ltd (Techpool Bio-Pharma) is a biopharmaceutical company. The company manufactures urinary protein biopharmaceuticals in critical care conditions. The company’s products include ulinastatin for injection, urinary kallidinogenase for injection, urokinase for injection and iron sucrose injection. It also offers national class-II new drug techpool roan, global-pioneering Class-I new drug kailikang and medicine in the treatment of osseous metastases. Techpool Bio-Pharma conducts research and development activities to develop new products. The company operates its offices in Guangzhou City, Luwan and Chaoyang, China. Techpool Bio-Pharma is headquartered in Guangzhou City, China.

Techpool Bio-Pharma Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Techpool Bio-Pharma Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Techpool Bio-Pharma Enters Into Licensing Agreement With Roche For Antineoplastic Drug 11
Acquisition 12
Shanghai Pharma to Acquire 26.34% Stake in Techpool Bio-Pharma from Takeda Pharma for USD143.4 Million 12
Sunrise Bright to Acquire 25% Stake in Techpool Bio-Pharma from Takeda Pharma for USD135.8 Million 13
Techpool Bio-Pharma Co Ltd – Key Competitors 14
Techpool Bio-Pharma Co Ltd – Key Employees 15
Techpool Bio-Pharma Co Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Techpool Bio-Pharma Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Techpool Bio-Pharma Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Techpool Bio-Pharma Enters Into Licensing Agreement With Roche For Antineoplastic Drug 11
Shanghai Pharma to Acquire 26.34% Stake in Techpool Bio-Pharma from Takeda Pharma for USD143.4 Million 12
Sunrise Bright to Acquire 25% Stake in Techpool Bio-Pharma from Takeda Pharma for USD135.8 Million 13
Techpool Bio-Pharma Co Ltd, Key Competitors 14
Techpool Bio-Pharma Co Ltd, Key Employees 15
Techpool Bio-Pharma Co Ltd, Other Locations 16

List of Figures
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Techpool Bio-Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Techpool Bio-Pharma Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Techpool Bio-Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IOI Corporation Berhad:企業の戦略・SWOT・財務分析
    IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mylan NV (MYL):医療機器:M&Aディール及び事業提携情報
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines, and consumer healthcare products. It offers pharmaceutical products in multiple forms for various disease conditions related to respiratory and allerg …
  • DBV Technologies SA (DBV):企業の財務・戦略的SWOT分析
    Summary DBV Technologies SA (DBV) is a biopharmaceutical company that develops products for the diagnosis and treatment of food and pediatric allergies. The company develops and markets non-invasive epicutaneous delivery technology and products for healthcare markets. Its viaskin technology platform …
  • Navitas Limited (NVT):企業の財務・戦略的SWOT分析
    Navitas Limited (NVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Telenet Group Holding NV (TNET):企業の財務・戦略的SWOT分析
    Telenet Group Holding NV (TNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ramsay Health Care Ltd (RHC):企業の財務・戦略的SWOT分析
    Ramsay Health Care Ltd (RHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sonic Healthcare Ltd (SHL)-医療機器分野:企業M&A・提携分析
    Summary Sonic Healthcare Ltd (Sonic Healthcare) Sonic Healthcare is a medical diagnostics company that provides laboratory and diagnostic imaging services. The company provides laboratory medicine, pathology, radiology, diagnostic imaging and primary care medical services. It operates Australia's la …
  • Wellington Management Company LLP:企業の戦略・SWOT・財務情報
    Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report Summary Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Capri Holdings Ltd:企業の戦略・SWOT・財務分析
    Capri Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Capri Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Robert Walters Plc (RWA):企業の財務・戦略的SWOT分析
    Summary Robert Walters Plc (Robert Walters) is a recruitment and consultancy service provider. The company offers placements of professionals on permanent, contract and interim positions. It offers recruitment services for accountancy and finance, banking and financial services, executive search, pr …
  • Manz AG (M5Z)-エネルギー分野:企業M&A・提携分析
    Summary Manz AG (Manz) is a manufacturer of high-technology equipment. It produces displays, printed circuit boards and other components for electronic devices. The company provides production equipment for lithium-ion battery cells, super capacitors, battery systems, and capacitors. Manz offers ind …
  • Lakeview Hotel Investment Corp.:戦略・SWOT・企業財務分析
    Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report Summary Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Metalfrio Solutions SA:戦略・SWOT・企業財務分析
    Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report Summary Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PanaHome Corp:企業の戦略的SWOT分析
    PanaHome Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Access Bio Inc (950130):医療機器:M&Aディール及び事業提携情報
    Summary Access Bio Inc (Access Bio) is a medical device company that research, develops, manufactures and markets in-vitro diagnostics tests, biosensor, and molecular diagnostic products. The company provides in vitro diagnostic technology such as immunochemical, biochemical and molecular products. …
  • Carillion plc:戦略・SWOT・企業財務分析
    Carillion plc - Strategy, SWOT and Corporate Finance Report Summary Carillion plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Finning International Inc. (FTT):企業の財務・戦略的SWOT分析
    Finning International Inc. (FTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Ayala Corp (AC):企業の財務・戦略的SWOT分析
    Ayala Corp (AC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • The Coca-Cola Co:企業の戦略・SWOT・財務分析
    The Coca-Cola Co - Strategy, SWOT and Corporate Finance Report Summary The Coca-Cola Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hunter Douglas NV (HDG):企業の財務・戦略的SWOT分析
    Hunter Douglas NV (HDG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆